Company Filing History:
5 out of 622 
1 out of 1,187 
Years Active: 2010-2019
Title: Cherie Holcomb: Innovator in Nucleic Acid Detection
Introduction
Cherie Holcomb is a prominent inventor based in Oakland, CA (US). She has made significant contributions to the field of molecular biology, particularly in the detection of nucleic acids and organ transplant rejection. With a total of 5 patents to her name, her work has advanced the methodologies used in genetic analysis and transplantation medicine.
Latest Patents
Among her latest patents is the invention titled "Successive capture of nucleic acid by magnetic glass particles." This patent provides methods and components for the effective capture of nucleic acids using magnetic glass particles. Another notable patent is "Non-invasive early detection of solid organ transplant rejection by quantitative analysis of mixtures by deep sequencing of HLA gene amplicons using next generation systems." This invention outlines a method for detecting or assessing solid organ graft rejection by identifying donor-specific HLA alleles in a blood sample from a transplant recipient. It also includes a method for detecting maternal cells in the blood of an offspring.
Career Highlights
Cherie has worked with esteemed organizations such as Roche Molecular Systems, Inc. and The Scripps Research Institute. Her experience in these institutions has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of her notable coworkers include Russell G. Higuchi and Henry A. Erlich. Their collaborative efforts have further enhanced the impact of her inventions in the scientific community.
Conclusion
Cherie Holcomb's innovative work in nucleic acid detection and organ transplant rejection has positioned her as a key figure in molecular biology. Her patents reflect her commitment to advancing medical science and improving patient outcomes.